Literature DB >> 25370573

Loss of function of SWI/SNF chromatin remodeling genes leads to genome instability of human lung cancer.

Hai-Tao Huang1, Shao-Mu Chen1, Liang-Bin Pan1, Jie Yao1, Hai-Tao Ma1.   

Abstract

SWI/SNF chromatin remodeling complexes are frequently mutated in a variety of human cancers. We investigated the mutation incidence and the role of mSWI/SNF (BAF) complexes in human lung cancer. In the present study, we analyzed somatic mutations of BAF complexes and other driver mutated genes of lung carcinoma deposited in the Catalogue of Somatic Mutations in Cancer (COSMIC) database. BAF complexes were mutated in 282 of 803 (35.12%) lung carcinoma samples analyzed, ranking second to TP53. Significantly, BAF-mutated samples exhibited more genomic mutations than BAF wild-type ones. Moreover, a significant positive correlation existed between the BAF mutations and overall genomic mutations in these lung carcinoma samples (P<0.001, Pearson's correlation analysis). Specifically, the mutant-typing of 6 BAF genes, SMARCA4, ARID2, ARID1B, BCL11A, BCL11B and BRD9 was associated with more overall mutations in the lung carcinoma samples. A mutation reporter system was developed by means of the establishment of stable cell sublines with slippage-luciferase transcript in a lung adenocarcinoma cell line, Calu-3. SMARCA4, the most frequently mutated BAF gene in lung cancer, was stably knocked down by pSUPER constructs carrying short hairpin RNA (shRNA). Mutation ratios determined from the mutation reporters of Calu-3 cells were significantly increased upon stable SMARCA4 knockdown. We demonstrated that genetic mutations of BAF complexes lead to genome instability of lung carcinoma. Therefore, BAF complexes play an important role in maintaining genome stability in human lung cancer.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25370573     DOI: 10.3892/or.2014.3584

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  22 in total

1.  Identifying candidate genes for 2p15p16.1 microdeletion syndrome using clinical, genomic, and functional analysis.

Authors:  Hani Bagheri; Chansonette Badduke; Ying Qiao; Rita Colnaghi; Iga Abramowicz; Diana Alcantara; Christopher Dunham; Jiadi Wen; Robert S Wildin; Malgorzata Jm Nowaczyk; Jennifer Eichmeyer; Anna Lehman; Bruno Maranda; Sally Martell; Xianghong Shan; Suzanne Me Lewis; Mark O'Driscoll; Cheryl Y Gregory-Evans; Evica Rajcan-Separovic
Journal:  JCI Insight       Date:  2016-03-17

Review 2.  Facilitation of base excision repair by chromatin remodeling.

Authors:  John M Hinz; Wioletta Czaja
Journal:  DNA Repair (Amst)       Date:  2015-09-16

3.  The transcriptional repressor BCL11A promotes breast cancer metastasis.

Authors:  Darcie D Seachrist; Molly M Hannigan; Natasha N Ingles; Bryan M Webb; Kristen L Weber-Bonk; Peng Yu; Gurkan Bebek; Salendra Singh; Steven T Sizemore; Vinay Varadan; Donny D Licatalosi; Ruth A Keri
Journal:  J Biol Chem       Date:  2020-06-23       Impact factor: 5.157

Review 4.  Frequently mutated genes/pathways and genomic instability as prevention targets in liver cancer.

Authors:  Chinthalapally V Rao; Adam S Asch; Hiroshi Y Yamada
Journal:  Carcinogenesis       Date:  2016-11-12       Impact factor: 4.944

5.  Genetic analysis of a morphologically heterogeneous ovarian endometrioid carcinoma.

Authors:  Felipe C Geyer; Fresia Pareja; Kathleen A Burke; Anne M Schultheis; Yaser R Hussein; Jiqing Ye; Maria R De Filippo; Caterina Marchio; Gabriel S Macedo; Salvatore Piscuoglio; Raymond S Lim; Eugene Toy; Rajmohan Murali; Achim A Jungbluth; Jorge S Reis-Filho; Robert A Soslow; Britta Weigelt
Journal:  Histopathology       Date:  2017-06-16       Impact factor: 5.087

6.  Mutations in ARID2 are associated with intellectual disabilities.

Authors:  Linshan Shang; Megan T Cho; Kyle Retterer; Leandra Folk; Jennifer Humberson; Luis Rohena; Alpa Sidhu; Sheila Saliganan; Alejandro Iglesias; Patrik Vitazka; Jane Juusola; Anne H O'Donnell-Luria; Yufeng Shen; Wendy K Chung
Journal:  Neurogenetics       Date:  2015-08-04       Impact factor: 2.660

7.  SMARCA4/BRG1 Is a Novel Prognostic Biomarker Predictive of Cisplatin-Based Chemotherapy Outcomes in Resected Non-Small Cell Lung Cancer.

Authors:  Erica Hlavin Bell; Arup R Chakraborty; Xiaokui Mo; Ziyan Liu; Konstantin Shilo; Simon Kirste; Petra Stegmaier; Maureen McNulty; Niki Karachaliou; Rafael Rosell; Gerold Bepler; David P Carbone; Arnab Chakravarti
Journal:  Clin Cancer Res       Date:  2015-12-15       Impact factor: 12.531

8.  Genetic Variation and Recurrent Haplotypes on Chromosome 6q23-25 Risk Locus in Familial Lung Cancer.

Authors:  Anthony M Musolf; Claire L Simpson; Bilal A Moiz; Claudio W Pikielny; Candace D Middlebrooks; Diptasri Mandal; Mariza de Andrade; Michael D Cole; Colette Gaba; Ping Yang; Ming You; Yafang Li; Elena Y Kupert; Marshall W Anderson; Ann G Schwartz; Susan M Pinney; Christopher I Amos; Joan E Bailey-Wilson
Journal:  Cancer Res       Date:  2021-04-14       Impact factor: 13.312

Review 9.  The roles of SNF2/SWI2 nucleosome remodeling enzymes in blood cell differentiation and leukemia.

Authors:  Punit Prasad; Andreas Lennartsson; Karl Ekwall
Journal:  Biomed Res Int       Date:  2015-02-19       Impact factor: 3.411

10.  BRD9 Inhibition, Alone or in Combination with Cytostatic Compounds as a Therapeutic Approach in Rhabdoid Tumors.

Authors:  Katja F Krämer; Natalia Moreno; Michael C Frühwald; Kornelius Kerl
Journal:  Int J Mol Sci       Date:  2017-07-16       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.